Bureaucrats, checkuser, developer, editor, reviewer, Administrators, widgeteditor
1,951
edits
Changes
no edit summary
| group = Atypical AP
| otheruse = mood stabilizer
| CAS = 106266-06-2
| ChemSpiderID = 4895
| ATC = N05AX08
| pubchem = 5073
| drugbank = APRD00187
| medscape = 6283
| drugscom = risperidone
| emea =
| ftk = risperidon
| type equivalent = 1| equivalent_ref = <ref>Woods SW Chlorpromazine equivalent doses for the newer atypical antipsychotics ''J Clin Psychiatry'' 2003;'''64''':663-667</ref>| comparison = haloperidol| avail = 70| avail_ref = <ref name="informatorium">{{KNMP|risperidon}}</ref>| halflife = 3| halflife_ref = <ref name="informatorium" />| ct = 6| ct_ref = <ref>{{pts}}</ref>| administration = oral| dose = 0.25-4| dose_ref = <ref name="informatorium" />| DDD = Antipsychotic
| metabolization =
* Risperidone is principally metabolized by CYP2D6 to an active metabolite.
|<includeonly> isswitch = 1</includeonly>
}}
